Test Price
2,800 AED✅ Home Collection Available
STK11 Gene (Peutz-Jeghers Syndrome) Genetic Test in UAE | 2800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS, covering full STK11 gene sequencing and deletion/duplication analysis.
VIP Mobile Phlebotomy & Cold-Chain Home Collection
Hospital‑grade home collection (8 AM – 11 PM) with ISO‑certified cold‑chain transport, available daily.
Clinical Guidance
Telephonic post‑test clinical interpretation by DHA‑licensed physicians, including risk assessment and follow‑up recommendations.
Insurance
Direct billing verification via WhatsApp: +971 54 548 8731
Core Metrics at a Glance
- Price: 2,800 AED
- Turnaround Time: 3 – 4 Weeks
- Sample Type: Peripheral Whole Blood
- Methodology: Next‑Generation Sequencing (NGS)
- ICD-10-CM: Q85.8
- LOINC: 85196-1
- DHA License: 1143
Test Overview & Methodology
This comprehensive next‑generation sequencing (NGS) analysis of the STK11 tumor suppressor gene identifies germline mutations responsible for Peutz‑Jeghers syndrome — a hereditary condition marked by gastrointestinal polyps and elevated cancer risk. This DHA‑aligned test empowers oncologists, researchers, and at‑risk families with definitive molecular diagnosis and actionable surveillance plans.
| Feature | Our STK11 NGS Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Sequencing Depth | Full gene + exon‑level CNV analysis (≥100x) | Selected exons only |
| Variant Detection | SNVs, indels, large deletions/duplications | Point mutations, small indels |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
| Pre‑Test Genetic Counselling | Included (DHA‑compliant pedigree chart) | Often separate referral |
| Regulatory Basis | Federal Decree‑Law No. 45 of 2021 & Federal Law No. 2 of 2019 | Variable |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that an STK11 mutation diagnosis is a starting point, not a verdict. It enables tailored surveillance — such as regular gastrointestinal and breast imaging — that significantly reduces cancer mortality. Every result must be interpreted alongside your personal and family history to guide meaningfully protective care.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or adjust any prescribed medication without consulting your treating physician. This test is for genetic risk assessment only and does not replace ongoing medical therapy.
Safety Exclusion Criteria & ER Red Flags
- Individuals unable to provide informed consent or where a legal guardian is not physically present (per UAE Personal Data Protection Law and Medical Liability Law).
- Acute severe abdominal pain, vomiting, or bloody stools — seek emergency care immediately before proceeding with the test.
- Known bleeding disorders or anticoagulant therapy that cannot be safely paused for blood collection — consult your specialist for a risk assessment.
- Children below the age of consent without a court‑appointed medical guardian (UAE law compliance).
Patient FAQ & Clinical Guidance
1. What does the STK11 gene test reveal and how does it affect my cancer risk?
This test identifies inherited STK11 mutations that confirm Peutz‑Jeghers syndrome, a condition that markedly raises lifetime risks for gastrointestinal, breast, and other cancers. Early detection enables proactive surveillance and risk reduction.
2. Why is genetic counselling mandatory before sample collection?
Pre‑test genetic counselling ensures you understand the implications, draws a family pedigree, meets DHA informed‑consent standards, and aligns with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection and Federal Law No. 2 of 2019 on health data.
3. How soon can I expect results and what support follows?
Results are delivered within 3–4 weeks. A DHA‑licensed clinician will call you to explain findings, recommend surveillance strategies, and connect you with oncology specialists.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143). All genetic data handling complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your genetic information is encrypted, access‑controlled, and used solely for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | STK11 Gene (Peutz-Jeghers Syndrome) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily 8 AM – 11 PM) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene sequencing plus deletion/duplication analysis |
| ICD-10-CM Code | Q85.8 (Peutz-Jeghers syndrome) |
| LOINC Code | 85196-1 (STK11 gene full sequencing) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians